ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
29 announcements with these filters
CCL Products (India) Limited announced the exercise of 2,100 equity shares by employees under its 2022 ESOP scheme. The exercise price was Rs. 2 per share.
CCL Products (India) Limited allotted 6,785 equity shares to eligible employees under its Employee Stock Option Scheme – 2022.
CCL Products (India) Ltd held its 65th Annual General Meeting on September 08, 2026, through video conferencing. The meeting proceedings were formally concluded.
CCL Products (India) Limited has issued a notice for its 65th Annual General Meeting scheduled for September 8, 2026, to be conducted via video conference.
CCL Products (India) Ltd filed its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, pursuant to SEBI (LODR) regulations.
CCL Products (India) Ltd has filed its Annual Report for the financial year 2025-26, along with the notice for its 65th Annual General Meeting.
CCL Products (India) Ltd has allotted 4,200 equity shares following the exercise of employee stock options under its 2022 scheme.
ICRA assigned [ICRA] AA (Stable) and [ICRA] A1+ ratings to bank facilities of CCL Products (India) Limited, confirming the company's creditworthiness.
CCL Products reports strong volume-led growth in Q1 FY27, maintaining a focus on deleveraging and B2C expansion despite coffee price volatility.
CCL Products (India) Limited has fixed September 01, 2026, as the record date for the final dividend payment of Rs. 3 per equity share.
CCL Products India Ltd reported revenue from operations of ₹1,200 Cr (+13.7% YoY) and net profit of ₹116.9 Cr (+61.5% YoY) for Q1 FY27.
CCL Products (India) Limited allotted 2,000 equity shares upon exercise of options by employees under its CCL Employee Stock Option Scheme – 2022.
CCL Products (India) scheduled a board meeting on July 27, 2026. The board will consider Q1 financial results and fix the record date for final dividend.
CCL Products (India) Limited announced the exercise of 2,100 options under its 2022 ESOP scheme. The transaction involved shares with a face value of Rs. 2.
CCL Products clarified that recent trading volume increases are purely market-driven. The company confirmed compliance with all disclosure norms and denied any unannounced material information.
CCL Products (India) Limited allotted 88,027 equity shares under its 2022 ESOP scheme. The transaction value is approximately ₹0.02 Crore, following employee option exercises.
CCL Products (India) Limited allotted 40,656 equity shares following the exercise of employee stock options. The transaction valued at ₹0.01 Crore fulfills scheme obligations.
CCL Products reported strong FY26 results with 43% annual revenue growth and 25% PAT growth, driven by volume and high coffee prices.
CCL Products reported strong revenue growth of 46% for Q4 FY26, driven by significant volume increases and higher green coffee prices. Management remains confident in maintaining 15% volume and EBITDA growth despite global logistical challenges.
CCL Products (India) granted 1,61,850 and vested 1,48,473 stock options to employees. The company also announced a revised senior management leadership structure.
CCL Products (India) Limited recommended a final dividend of Rs. 3 per share for FY 2025-26. The board also approved audited financial results for the year.
CCL Products India Ltd reported revenue from operations of ₹1,224 Cr (+46.5% YoY) and net profit of ₹114.5 Cr (+12.4% YoY) for Q4 FY26.
CCL Products (India) Limited reported audited consolidated net profit of Rs. 388.11 Crore for FY2025-26. The Board recommended a final dividend of Rs. 3 per equity share (150%), taking the total dividend for the year to Rs. 5.75 per share. Results show strong growth with total consolidated income reaching Rs. 4,465.00 Crore.
CCL Products (India) Limited has scheduled a board meeting for May 7, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 2026 and recommend a final dividend. The company's trading window remains closed until May 9, 2026.
CCL Products (India) Limited has scheduled a board meeting on May 7, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 2026 and recommend a final dividend. The trading window remains closed until May 9, 2026.
CCL Products (India) Limited has scheduled a board meeting on May 7, 2026. The board will consider audited standalone and consolidated financial results for the year ended March 31, 2026, and recommend a final dividend. The trading window remains closed until May 9, 2026.
CCL Products (India) Ltd has scheduled a board meeting for May 07, 2026, to approve audited financial results for Q4 and FY 2025-26 and recommend a final dividend. The trading window for designated persons remains closed until May 09, 2026.
India Ratings & Research has revised the credit rating outlook for CCL Products (India) Limited to 'Stable' from 'Negative' for its INR 1,176 Crore bank facilities. The agency also affirmed the long-term rating at 'IND AA-'. The revision reflects steady capacity ramp-ups and improving EBITDA margins.
CCL Products (India) Ltd submitted its quarterly certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations for the period ended March 31, 2026. The certificate confirms the processing of share dematerialisation requests by its Registrar and Share Transfer Agent.